Coronary disease & ACSDiagnostic or prognostic study

AI-Enabled Electrocardiographic (ECG) Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations

JACC Cardiovasc IntervPublished

  • Diagnostic accuracy study
  • retrospective
  • multicentre
  • blinded artificial intelligence (AI) ECG analysis

Authors' conclusion

AI-based ECG analysis significantly improved STEMI detection, reduced FPAs, and enhanced the recognition of nonconventional presentations.

Study context

Population
Patients with suspected STEMI triggering emergent cardiac catheterization laboratory (CCL) activation at 3 US PCI centres, January 2020 to May 2024601 confirmed STEMI
Participants
1,032 patients
Comparison
AI ECG analysis vs standard triage
Outcome
Diagnostic accuracy vs reference standard (angiographically confirmed culprit lesion with positive enzymes)

Performance

As reported in the abstract

Diagnostic performance for STEMI
Test or modelSensitivityFPA rateSpecificityAUC
AI ECG553 of 601 [92.0%; 95% CI: 89.7%-94.1%]34 of 431 [7.9%; 95% CI: 6.4%-9.6%]431 of 531 [81.0%; 95% CI: 77.2%-84.5%]0.94 (95% CI: 0.92-0.95)
Standard triage427 of 601 [71.0%; 95% CI: 67.4%-74.6%]180 of 431 [41.8%; 95% CI: 38.9%-44.7%]154 of 531 [29.0%; 95% CI: 24.8%-33.4%]
  • AI ECG vs Standard triage: P < 0.001 — sensitivity, FPA rate and specificity (P < 0.001 for all)

Further findings

Reclassification of biomarker-negative false positive activations (FPAs) by AI ECG
91% · 277 events
  • Reclassification of biomarker-negative FPAs by AI ECG: 277 of 306 correctly reclassified

AI ECG performance in challenging subgroups (AF, bundle branch block, STEMI equivalents)

Consistent performance across clinically challenging subgroups

Original publication

AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations. JACC Cardiovasc Interv. Published 28 October 2025. doi:10.1016/j.jcin.2025.10.018

Summarised from the published abstract; every number is checked against it